Nicholas P McAndrew

5PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.

Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto

|Oct 12, 2021
Clinical Review on the Management of Hormone Receptor-Positive Metastatic Breast Cancer.

Nicholas P McAndrew, Richard S Finn

|Oct 09, 2021
A careful reassessment of anthracycline use in curable breast cancer.

Sara Alsterlind Hurvitz, Nicholas P McAndrew, Aditya Bardia

|Jan 23, 2021
Effects of systemic inflammation on relapse in early breast cancer.

Nicholas P McAndrew, Lisa Bottalico, Clementina Mesaros

|Jul 10, 2020
Early treatment-related neutropenia predicts response to palbociclib.

Nicholas P McAndrew, Mark A Dickson, Amy S Clark

Pageof 1